Cargando…

Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases

Some systemic rheumatic diseases and disorders, especially fibrotic and vascular disorders, are often refractory to corticosteroid therapy. Recently, ever accumulating evidence suggests that platelet-derived growth factor (PDGF) is involved in those refractory diseases. Imatinib mesylate inhibits th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kameda, Hideto, Suzuki, Miyuki, Takeuchi, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155225/ https://www.ncbi.nlm.nih.gov/pubmed/21901078

Ejemplares similares

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

What is the future of CCR5 antagonists in rheumatoid arthritis?
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Platelet-Derived Microparticles and Autoimmune Diseases
por: Li, Xiaoshuai, et al.
Publicado: (2023)

Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis
por: Okuyama, Ayumi, et al.
Publicado: (2010)

Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases: Perspectives and therapeutic aspects
por: Harifi, Ghita, et al.
Publicado: (2016)

IgG4-Related Disease without Overexpression of IgG4: Pathogenesis Implications
por: Nishina, Naoshi, et al.
Publicado: (2012)

Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study
por: Nakamura, Seiji, et al.
Publicado: (2016)

Complement as a Therapeutic Target in Systemic Autoimmune Diseases
por: Galindo-Izquierdo, María, et al.
Publicado: (2021)

Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells
por: Takeuchi, H, et al.
Publicado: (2004)

Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice
por: Liu, Ye, et al.
Publicado: (2020)

Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta
por: Askoxylakis, Vasileios, et al.
Publicado: (2012)

The Risk Factors of Exacerbation in Interstitial Pneumonia With Autoimmune Features: A Single-Center Observational Cohort Study
por: Murata, Okinori, et al.
Publicado: (2021)

Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization
por: Sadiq, Mohammad Ali, et al.
Publicado: (2015)

Platelet-Derived Growth Factors: A New Therapeutic Opportunity for Treating Cardiac Fibrosis?
por: Mouton, Alan J.
Publicado: (2023)

Platelets in Skin Autoimmune Diseases
por: Liu, Xiaobo, et al.
Publicado: (2019)

Freeze-Dried Platelet-Rich Plasma Induces Osteoblast Proliferation via Platelet-Derived Growth Factor Receptor-Mediated Signal Transduction
por: Kinoshita, Hideyuki, et al.
Publicado: (2020)

Association between the Platelet-Derived Growth Factor/Platelet-Derived Growth Factor Receptor System and Risk of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Li, Feiyan, et al.
Publicado: (2022)

Performance of the Revised Classification Criteria for Systemic Autoimmune Rheumatic Diseases and Their Overlap Syndromes
por: Inoue, Yuki, et al.
Publicado: (2022)

Platelet-derived growth factor in chemotactic for fibroblasts
Publicado: (1982)

Retracted: Association between the Platelet-Derived Growth Factor/Platelet-Derived Growth Factor Receptor System and Risk of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Expression of Platelet‐derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Human Bladder Cancer
por: Tanaka, Tsutomu, et al.
Publicado: (1999)

Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds
por: Goldsmith, Zachary K., et al.
Publicado: (2018)

The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
por: Solinc, Julien, et al.
Publicado: (2022)

Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
por: Iragavarapu-Charyulu, Vijaya, et al.
Publicado: (2020)

Interactions between the receptors for platelet-derived growth factor and epidermal growth factor
Publicado: (1983)

Structural and functional aspects of platelet-derived growth factor.
por: Heldin, C. H., et al.
Publicado: (1988)

Platelet-derived growth factor signaling in human malignancies
por: Liu, Kun-Wei, et al.
Publicado: (2011)

Platelet-derived growth factor in glioblastoma—driver or biomarker?
por: Westermark, Bengt
Publicado: (2014)

Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma
por: Guo, Yi, et al.
Publicado: (2013)

Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation
por: Bian, Qi, et al.
Publicado: (2021)

Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
por: Leng, Qianru, et al.
Publicado: (2022)

Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis
por: Arinaga-Hino, Teruko, et al.
Publicado: (2022)

Autoimmune Epithelitis and Chronic Inflammation in Sjögren’s Syndrome-Related Dry Eye Disease
por: Ogawa, Yoko, et al.
Publicado: (2021)

Nerve Growth Factor and Autoimmune Diseases
por: Terracina, Sergio, et al.
Publicado: (2023)

Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells
Publicado: (1990)

B cells as a therapeutic target in autoimmune disease
por: Goronzy, Jörg J, et al.
Publicado: (2003)

Therapeutic targeting of STAT pathways in CNS autoimmune diseases
por: Egwuagu, Charles E., et al.
Publicado: (2013)

GM-CSF as a therapeutic target in autoimmune diseases
por: Shiomi, Aoi, et al.
Publicado: (2016)

TIGIT as a Promising Therapeutic Target in Autoimmune Diseases
por: Yue, Chenran, et al.
Publicado: (2022)

The role of inflammation in autoimmune disease: a therapeutic target
por: Xiang, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iq05j3vflf3gpreoafqknrhd3v